Fingolimod in children with Rett syndrome: the FINGORETT study

BACKGROUND: Rett syndrome (RS) is a severe neurodevelopmental disorder for which there is no approved therapy. This study aimed to assess safety and efficacy of oral fingolimod in children with RS using a pre-post and case–control design. METHODS: At the University of Basel Children’s Hospital, Base...

Descripción completa

Detalles Bibliográficos
Autores principales: Naegelin, Yvonne, Kuhle, Jens, Schädelin, Sabine, Datta, Alexandre N., Magon, Stefano, Amann, Michael, Barro, Christian, Ramelli, Gian Paolo, Heesom, Kate, Barde, Yves-Alain, Weber, Peter, Kappos, Ludwig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789265/
https://www.ncbi.nlm.nih.gov/pubmed/33407685
http://dx.doi.org/10.1186/s13023-020-01655-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789265/
https://www.ncbi.nlm.nih.gov/pubmed/33407685
http://dx.doi.org/10.1186/s13023-020-01655-7

Ejemplares similares